previous compound ID: 2636 next compound
InChIKey: XTKDAFGWCDAMPY-UHFFFAOYSA-N
SMILES: C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "D Rotin" "SD Macknight" "DY Thomas" "E Matthes" "J Goepp" "J Liao" "GW Carlile" "JW Hanrahan" "R Robert"

chemical graph of compound 2636





CID is 15443
synonyms found at PubChem are:
Azaperone, 1649-18-9, Stresnil, Azaperon, Fluoperidol, Suicalm, Azeperone, Eucalmyl, Sedaperone vet, Azaperona, Azaperonum, R-1929, NSC 170976, Azaperonum [INN-Latin], Azaperona [INN-Spanish], 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-, UNII-19BV78AK7W, 1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine, C19H22FN3O, CCRIS 1586, 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone, 4'-Fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone, EINECS 216-715-8, R 1929, BRN 0565491, MLS003106751, 19BV78AK7W, CHEMBL340211, CHEBI:88301, 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one, 1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one, 1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-, NSC170976, NCGC00016590-01, Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-, CAS-1649-18-9, 1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one, DSSTox_CID_25361, DSSTox_RID_80826, DSSTox_GSID_45361, 4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone, 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one, 1-(4-Fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone, BUTYROPHENONE, 4'-FLUORO-4-(4-(2-PYRIDYL)-1-PIPERAZINYL)-, SMR001233462, SR-05000001712, Azaperone [USAN:INN:BAN], azaperone(usp), Azaperone [USAN:USP:INN:BAN], Stresnil (TN), Azaperone (USP/INN), AC1Q4NJV, Prestwick0_001117, Prestwick1_001117, Prestwick2_001117, Prestwick3_001117, Spectrum2_001250, Spectrum3_001966, D0Q7FM, AC1L25WI, BSPBio_001254, BSPBio_003566, 5-23-03-00041 (Beilstein Handbook Reference), MLS002154163, SCHEMBL121134, SPECTRUM1505332, SPBio_001160, SPBio_003117, BPBio1_001379, DTXSID2045361, CTK8E9220, KBio3_002914, MolPort-002-508-199, XTKDAFGWCDAMPY-UHFFFAOYSA-N, HMS1571O16, HMS1922D20, HMS2090K03, HMS2093D03, HMS2098O16, HMS2230C17, HMS3369I10, HMS3652D15, HMS3715O16, Pharmakon1600-01505332, BCP12176, HY-B1470, ZINC2596977, Tox21_110512, BBL011031, BDBM50036733, CCG-39158, NSC758969, PDSP1_000828, PDSP2_000815, s4219, STK802185, AKOS005622715, Tox21_110512_1, AM84563, API0001568, CS-5158, KS-5204, MCULE-4749695585, NSC-170976, NSC-758969, VA10355, NCGC00016590-02, NCGC00016590-03, NCGC00016590-04, NCGC00016590-06, NCGC00016590-08, NCGC00095171-01, NCGC00095171-02, NCGC00095171-03, AN-49615, CC-24215, L994, LS-48432, SBI-0206748.P001, AB0014996, TC-063579, WLN: T6N DNTJ D3VR DF& A- BT6NJ, AB00514057, FT-0602908, ST24037370, Azaperone, VETRANAL(TM), analytical standard, D02620, K-5140, AB00514057-06, AB00514057_07, 649A189, A810604, C-19900, L000791, I06-0254, J-010171, SR-05000001712-1, SR-05000001712-3, BRD-K45861246-001-05-0, BRD-K45861246-001-08-4, Azaperone, British Pharmacopoeia (BP) Reference Standard, {4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone}, 4'-Fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone, Azaperone, European Pharmacopoeia (EP) Reference Standard, Azaperone, United States Pharmacopeia (USP) Reference Standard, Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-}, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanon, 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butznone, 1-(4-fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one, 1-Butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-}, 1-(4-Fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(Azaperone), 4 inverted exclamation mark -fluoro-4-(4-(2-pyridyl)-1-piperazinyl)-butyrophenon, 4 inverted exclamation marka-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone